Skip to main content
Figure 1 | Virology Journal

Figure 1

From: Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge

Figure 1

Cell surface expression of membrane-bound immunomodulator fusion constructs. Cell surface immunofluorescent staining of wild-type MDCK cells (A, B, C) and MDCK CYT-IVAC producer cells expressing membrane-bound mouse GM-CSF/HA (D), IL-2/HA (E), or IL-4/HA (F). Paraformaldehyde fixed cells were labeled using rat anti-GM-CSF (A, D), anti-IL2 (B, E) or anti-IL4 (C, F) specific antibodies followed by Alexa Flour® 488 conjugated secondary antibody.

Back to article page